The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator
In all four trials, treatment with the DPP-4 inhibitor produced meaningful decreases in glycated hemoglobin
It is needed for neurotransmitter reuptake, endocytosis of SV, and presynaptic vesicles, let alone maintain the concentration gradients of ions across the membrane
Buzil ER, Dorneanu OS, Trofin F, Sima CM, Iancu LS (2025) Assessing Salmonella Typhi pathogenicity and prevention: the crucial role of vaccination in combating typhoid fever
Are peptide stacks safe